Covishield Dose
- All
- News
- Videos
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Serum Institute To Provide 2 Crore Covishield Doses To Centre For Free
The Serum Institute of India has offered two crore doses of Covishield vaccine to the central government free of cost amid a rise in COVID-19 cases in some countries, official sources said today.
-
"People Fed Up Of Covid, Vaccines. I Am Also Fed Up": Adar Poonawalla
Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday said the vaccine manufacturer stopped the production of Covishield vaccine starting December 2021.
-
Covishield Usage As Booster Highest Compared To Other Vaccines: Report
The usage of Covishield has been the highest as the precaution dose for COVID-19 as compared to other vaccines, said Union Health Ministry sources on Tuesday.
-
Corbevax Approved As Booster Dose For Adults Vaccinated With Covaxin, Covishield
The government on Wednesday approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin.
-
Covaxin, Covishield Recipients Had Same Infection Rate In 3rd Wave: Study
Seventy per cent of people who received a booster dose of Covid vaccine did not get infected during the third wave, according to a new study that covered around 6,000 people in India.
-
Serum Institute Halts Vaccine Production Over Millions Of Unused Doses
Serum Institute of India Ltd., the world's largest vaccine manufacturer and a key supplier of Covid-19 inoculations to developing countries, has stopped making fresh batches of shots after its stockpile grew to 200 million doses amid a global supply
-
Covishield, Covaxin Prices Cut To Rs 225 Day Before Booster Drive Begins
Serum Institute of India CEO Adar Poonawalla and Bharat Biotech cofounder Suchitra Ella today said that the decision was taken after discussions with the Centre.
-
Covishield Booster At Rs 600 Plus Tax: Adar Poonawalla To NDTV
Mr Poonawala told NDTV that Covishield will cost Rs 600 plus taxes (same as before) and Covovax, once approved as a booster, will be available for Rs.900 plus taxes.
-
Booster Dose Of Covid Vaccine Needed To Fight Against Omicron: Study
Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both with regard to Omicron variant, a study done by the National Institute of Virology indicated.
-
Covishield Dose Gap Reduced To 8-16 Weeks From 12-16
India's apex body on immunisation NTAGI has recommended administering the second dose of COVID-19 vaccine Covishield between eight and 16 weeks after the first dose.
-
Reports That 50 Lakh Covishield Doses May Go Waste This Month "Misleading": Centre
The Union Health Ministry today refuted as "misleading" media reports which claimed that 50 lakh unused Covishield doses may go waste by the end of this month.
-
Boosters Will Not Be Mix-And-Match, Announces Government
There will be no mix-and-match of vaccines for those eligible to get a 'precautionary' third dose, Dr VK Paul, the head of India's Covid task force, said Wednesday, meaning those who got Covishield will get the same, as will those who got Covaxin.
-
100 Crore Covishield Doses Given In India, Abroad, Says Vaccine Maker
Over 100 crore Covishield doses have been given in India and abroad which is a testimony of its safety and efficacy, Serum Institute has informed the DCGI
-
AstraZeneca Covid Vaccine Protection Wanes After 3 Months: Lancet Study
The protection offered by the Oxford-Astra Zeneca COVID-19 vaccine declines after three months of receiving two doses of the preventive, according to a study published in The Lancet journal.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Serum Institute To Provide 2 Crore Covishield Doses To Centre For Free
The Serum Institute of India has offered two crore doses of Covishield vaccine to the central government free of cost amid a rise in COVID-19 cases in some countries, official sources said today.
-
"People Fed Up Of Covid, Vaccines. I Am Also Fed Up": Adar Poonawalla
Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday said the vaccine manufacturer stopped the production of Covishield vaccine starting December 2021.
-
Covishield Usage As Booster Highest Compared To Other Vaccines: Report
The usage of Covishield has been the highest as the precaution dose for COVID-19 as compared to other vaccines, said Union Health Ministry sources on Tuesday.
-
Corbevax Approved As Booster Dose For Adults Vaccinated With Covaxin, Covishield
The government on Wednesday approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin.
-
Covaxin, Covishield Recipients Had Same Infection Rate In 3rd Wave: Study
Seventy per cent of people who received a booster dose of Covid vaccine did not get infected during the third wave, according to a new study that covered around 6,000 people in India.
-
Serum Institute Halts Vaccine Production Over Millions Of Unused Doses
Serum Institute of India Ltd., the world's largest vaccine manufacturer and a key supplier of Covid-19 inoculations to developing countries, has stopped making fresh batches of shots after its stockpile grew to 200 million doses amid a global supply
-
Covishield, Covaxin Prices Cut To Rs 225 Day Before Booster Drive Begins
Serum Institute of India CEO Adar Poonawalla and Bharat Biotech cofounder Suchitra Ella today said that the decision was taken after discussions with the Centre.
-
Covishield Booster At Rs 600 Plus Tax: Adar Poonawalla To NDTV
Mr Poonawala told NDTV that Covishield will cost Rs 600 plus taxes (same as before) and Covovax, once approved as a booster, will be available for Rs.900 plus taxes.
-
Booster Dose Of Covid Vaccine Needed To Fight Against Omicron: Study
Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both with regard to Omicron variant, a study done by the National Institute of Virology indicated.
-
Covishield Dose Gap Reduced To 8-16 Weeks From 12-16
India's apex body on immunisation NTAGI has recommended administering the second dose of COVID-19 vaccine Covishield between eight and 16 weeks after the first dose.
-
Reports That 50 Lakh Covishield Doses May Go Waste This Month "Misleading": Centre
The Union Health Ministry today refuted as "misleading" media reports which claimed that 50 lakh unused Covishield doses may go waste by the end of this month.
-
Boosters Will Not Be Mix-And-Match, Announces Government
There will be no mix-and-match of vaccines for those eligible to get a 'precautionary' third dose, Dr VK Paul, the head of India's Covid task force, said Wednesday, meaning those who got Covishield will get the same, as will those who got Covaxin.
-
100 Crore Covishield Doses Given In India, Abroad, Says Vaccine Maker
Over 100 crore Covishield doses have been given in India and abroad which is a testimony of its safety and efficacy, Serum Institute has informed the DCGI
-
AstraZeneca Covid Vaccine Protection Wanes After 3 Months: Lancet Study
The protection offered by the Oxford-Astra Zeneca COVID-19 vaccine declines after three months of receiving two doses of the preventive, according to a study published in The Lancet journal.
